Baltimore, MD, United States of America

Michael Porter

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Michael Porter: Innovator in HPV Detection and Chemical Lysis

Introduction

Michael Porter is a distinguished inventor based in Baltimore, MD (US), known for his significant contributions to the field of medical diagnostics. He holds a total of seven patents, showcasing his innovative approach to solving complex problems in healthcare.

Latest Patents

Among his latest patents is an assay for detecting closely-related serotypes of human papillomavirus (HPV). This real-time Taq-Man PCR assay is designed to detect multiple serotypes of HPV, exceeding the number of colorimetric channels available for detection. The method involves combining a biological sample with three oligonucleotide primer/probe sets, allowing for the specific identification of various serotypes. The first two primer/probe sets are degenerate with respect to each other, while the third set is specifically designed to discriminate a third serotype, enhancing the assay's accuracy.

Another notable patent involves methods and compositions for direct chemical lysis. This innovative composition includes an assay-compatible buffer and surfactant, which, when combined with a specimen storage composition, prevents undesired modifications to nucleic acids and proteins. This method allows for direct nucleic acid extraction from biological samples without the need for time-consuming steps like centrifugation or the use of enzymes such as proteinase K.

Career Highlights

Michael Porter is currently associated with Becton Dickinson and Company Limited, where he continues to advance his research and development efforts in medical diagnostics. His work has significantly impacted the efficiency and effectiveness of diagnostic assays.

Collaborations

Throughout his career, Porter has collaborated with notable colleagues, including Chi Chen and Hugh J Peck, contributing to various innovative projects and enhancing the scope of his research.

Conclusion

Michael Porter exemplifies the spirit of innovation in the medical field, particularly in the areas of HPV detection and chemical lysis. His patents reflect a commitment to improving diagnostic methods, ultimately benefiting healthcare professionals and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…